Scott Fung

Intestinal microbiota in patients with nonalcoholic fatty liver disease

Marialena Mouzaki, Elena M. Comelli, Bianca M. Arendt et al. · Hepatology · 2013 · 737 citations · Full text

Life Sciences, Microbiology, Pathology +17

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 458 citations

Pharmacy, Infectious Diseases, Pharmacology +11

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 423 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

Marialena Mouzaki, Alice Y. Wang, Robert Bandsma et al. · PLoS ONE · 2016 · 384 citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids

Bianca M. Arendt, Elena M. Comelli, David W.L. et al. · Hepatology · 2015 · 341 citations · Full text

Life Sciences, Biochemistry, Gene Expression Analysis +14